How much is ImmunoScape worth in 2026?

ImmunoScape has a current valuation of $80.8M based on their Later Stage VC round and secondary market data.

How much funding has ImmunoScape raised?

ImmunoScape has raised $60.4M in total funding across 0 funding rounds.

ImmunoScape

Website

ImmunoScape valuation and funding history | Last updated: June 13, 2025

Current Valuation

$80.8M

As of June 13, 2025

Total Funding Raised

$60.4M

Last Round

Later Stage VC

$33.3M

Last Funding

Jun 2025

Funding date

Capital Efficiency

1.34x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

ImmunoScape is currently valued at $80.8M as of June 13, 2025. The company has raised a total of $60.4M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.34x, ImmunoScape has achieved a valuation that is 1.34 times the total capital raised.

Track ImmunoScape Valuation Updates

Get notified when ImmunoScape raises new funding or valuation changes

Explore More Data

Detailed analysis for ImmunoScape

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock ImmunoScape's valuation history, funding rounds, and growth metrics.

No credit card required

What is ImmunoScape Worth in 2026?

ImmunoScape is a leading private company in the technology sector. Track ImmunoScape's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How ImmunoScape Valuation is Determined

Private company valuations like ImmunoScape's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.